Ftse Mib
37.677,27
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.592,36
-0,40%
NASDAQ
17.474,53
0,04%
Bitcoin
82.635,13
5,30%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Coherus BioSciences Inc (CHRS) Coherus BioSciences Inc (CHRS) Notizie

Coherus BioSciences Inc

CHRS
1,015
-0,025 (-2,40%)
Ultimo aggiornamento: 19:17:37
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202521:31EDGAR2Form 8-K - Current report
10/3/202521:12GLOBECoherus BioSciences Reports Fourth Quarter, Full Year 2024..
04/3/202514:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/3/202514:32EDGAR2Form 8-K - Current report
03/3/202514:30GLOBECoherus to Report Fourth Quarter and Full Year 2024..
24/2/202515:08GLOBECoherus Management to Participate at the 45th Annual TD..
13/2/202522:01EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
28/1/202523:24EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
23/1/202501:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202501:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202513:00GLOBECoherus Presents Final Phase 2 Clinical Casdozokitug..
14/1/202522:06EDGAR2Form PREM14A - Preliminary proxy statements relating to..
13/1/202522:25EDGAR2Form 8-K - Current report
10/1/202522:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202514:00GLOBECoherus Management to Present at the 43rd Annual J.P. Morgan..
08/1/202502:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202502:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202414:30GLOBECoherus to Present Final Phase 2 Casdozokitug Combination..
17/12/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:29EDGAR2Form 8-K - Current report
04/12/202422:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/12/202423:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/12/202420:20APSCalifornia-Based Biotech Rallies Strongly Following $558.4M..
03/12/202413:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/12/202413:11EDGAR2Form 8-K - Current report
03/12/202413:00GLOBECoherus Announces Agreement to Divest UDENYCA® Franchise for..
27/11/202422:01GLOBECoherus Management to Participate in the 2024 Citi Global..
06/11/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:23EDGAR2Form 8-K - Current report
06/11/202422:01GLOBECoherus BioSciences Reports Third Quarter 2024 Financial..
30/10/202421:20GLOBECoherus to Report Third Quarter 2024 Financial Results on..
13/9/202423:15EDGAR2Form 8-K - Current report
09/8/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202422:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:23EDGAR2Form 8-K - Current report
08/8/202422:05GLOBECoherus BioSciences Reports Second Quarter 2024 Financial..
01/8/202415:00GLOBECoherus to Report Second Quarter 2024 Financial Results on..
25/7/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/6/202414:26GLOBECoherus BioSciences Announces Divestiture of YUSIMRY..
06/6/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202400:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/6/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202415:11EDGAR2Form 8-K - Current report
05/6/202415:00GLOBECoherus BioSciences Appoints Rita Karachun, CPA, CGMA to its..
Apertura: 1,04 Min: 0,9501 Max: 1,121
Chiusura: 1,04

La tua Cronologia

NASDAQ
CHRS
Coherus BioSciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci